Empery Asset Management’s Statera Biopharma STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-333,016
Closed -$105K – 84
2022
Q1
$105K Buy
+333,016
New +$356K 0.49% 30

Other funds holding STAB

Empery Asset Management's STAB Position: Q2 2022 in Review

Empery Asset Management sold out of Statera Biopharma (STAB) in Q2 2022, closing a stake of 333,016 shares — an estimated $105K sold.

Empery Asset Management first reported a position in STAB in Q1 2022 and held it in 1 quarter. The position peaked at $105K in Q1 2022. 35 funds tracked by Wall St. Rank hold STAB as of Q2 2022.

  • Empery Asset Management reported no remaining Statera Biopharma position as of Q2 2022 after selling out during the quarter.
  • Empery Asset Management sold 333,016 Statera Biopharma shares in Q2 2022, an estimated $105K.
  • Empery Asset Management first reported a position in Statera Biopharma in Q1 2022 and held it in 1 quarter.
  • Empery Asset Management's Statera Biopharma position peaked at $105K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma as of Q2 2022.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.